Two Sigma Advisers’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-19,500
Closed -$158K 2377
2024
Q2
$158K Sell
19,500
-300
-2% -$2.19K ﹤0.01% 2255
2024
Q1
$148K Sell
19,800
-6,700
-25% -$51K ﹤0.01% 2263
2023
Q4
$180K Sell
26,500
-11,300
-30% -$75.4K ﹤0.01% 2252
2023
Q3
$246K Sell
37,800
-30,313
-45% -$178K ﹤0.01% 2042
2023
Q2
$373K Sell
68,113
-11,587
-15% -$78.9K ﹤0.01% 1913
2023
Q1
$750K Buy
79,700
+4,300
+6% +$47.5K ﹤0.01% 1767
2022
Q4
$881K Buy
75,400
+10,700
+17% +$118K ﹤0.01% 1629
2022
Q3
$721K Buy
+64,700
New +$863K ﹤0.01% 1689
2018
Q1
Sell
-5,163
Closed -$49K 2339
2017
Q4
$49K Sell
5,163
-780
-13% -$7.86K ﹤0.01% 2189
2017
Q3
$64K Sell
5,943
-2,490
-30% -$22.9K ﹤0.01% 2141
2017
Q2
$87K Sell
8,433
-1,840
-18% -$23.2K ﹤0.01% 2186
2017
Q1
$144K Sell
10,273
-760
-7% -$11.6K ﹤0.01% 2242
2016
Q4
$167K Sell
11,033
-3,182
-22% -$48.2K ﹤0.01% 2225
2016
Q3
$230K Sell
14,215
-3,598
-20% -$59.3K ﹤0.01% 1989
2016
Q2
$283K Sell
17,813
-5,760
-24% -$102K ﹤0.01% 1741
2016
Q1
$596K Sell
23,573
-2,939
-11% -$90.3K ﹤0.01% 1383
2015
Q4
$859K Sell
26,512
-3,019
-10% -$113K 0.01% 1100
2015
Q3
$1.05M Buy
29,531
+11,339
+62% +$512K 0.01% 992
2015
Q2
$1.08M Buy
18,192
+6,988
+62% +$470K 0.01% 1089
2015
Q1
$874K Sell
11,204
-2,110
-16% -$163K 0.01% 1132
2014
Q4
$1.03M Buy
13,314
+3,290
+33% +$215K 0.01% 1158
2014
Q3
$639K Sell
10,024
-2,570
-20% -$175K ﹤0.01% 1391
2014
Q2
$905K Buy
12,594
+2,300
+22% +$178K 0.01% 1235
2014
Q1
$910K Buy
10,294
+1,330
+15% +$104K 0.01% 1208
2013
Q4
$702K Sell
8,964
-2,720
-23% -$222K 0.01% 1363
2013
Q3
$1.03M Sell
11,684
-2,557
-18% -$234K 0.01% 939
2013
Q2
$1.23M Buy
+14,241
New +$1.18M 0.02% 755

Other funds holding HHS

Two Sigma Advisers's HHS Position: Q3 2024 in Review

Two Sigma Advisers sold out of Harte-Hanks (HHS) in Q3 2024, closing a stake of 19,500 shares — an estimated $158K sold.

Two Sigma Advisers first reported a position in HHS in Q2 2013 and held it in 27 quarters. The position peaked at $1.23M in Q2 2013. 25 funds tracked by Wall St. Rank hold HHS as of Q3 2024.

  • Two Sigma Advisers reported no remaining Harte-Hanks position as of Q3 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 19,500 Harte-Hanks shares in Q3 2024, an estimated $158K.
  • Two Sigma Advisers first reported a position in Harte-Hanks in Q2 2013 and held it in 27 quarters.
  • Two Sigma Advisers's Harte-Hanks position peaked at $1.23M in Q2 2013.
  • 25 funds tracked by Wall St. Rank held Harte-Hanks as of Q3 2024.

Based on Two Sigma Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.